Results 321 to 330 of about 2,696,673 (357)
Digital twins are integral to personalizing medicine and improving public health. [PDF]
Johnson B, Curtius K.
europepmc +1 more source
Familial resemblance in dietary intake among singletons, twins, and spouses: a meta-analysis of family-based observations. [PDF]
Teymoori F+14 more
europepmc +1 more source
Utilization of precision medicine digital twins for drug discovery in Alzheimer's disease. [PDF]
Ren Y, Pieper AA, Cheng F.
europepmc +1 more source
Environmental Factor Index (EFI): A Novel Approach to Measure the Strength of Environmental Influence on DNA Methylation in Identical Twins. [PDF]
Takenaka Y+2 more
europepmc +1 more source
Exploring Monogenic, Polygenic, and Epigenetic Models of Common Variable Immunodeficiency. [PDF]
Ranjbarnejad T+6 more
europepmc +1 more source
Parkinson's disease in twins [PDF]
Among nine monozygotic (MZ) and 12 dizygotic (DZ) twin pairs in which an index case had typical Parkinson's disease (PD) or PD with associated dementia, three MZ and three DZ pairs were concordant. Three of the six affected co-twins were first diagnosed during the study.
H. J. Friedrich+4 more
openaire +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Clinical Nuclear Medicine, 1995
Tc-99m HMPAO SPECT was used to evaluate regional blood flow in one monozygotic twin who had angiographically proven moyamoya disease. Focal and global reduced regional cerebral perfusion were observed in both patients with Tc-99m HMPAO SPECT studies.
Dirlik, A+3 more
openaire +4 more sources
Tc-99m HMPAO SPECT was used to evaluate regional blood flow in one monozygotic twin who had angiographically proven moyamoya disease. Focal and global reduced regional cerebral perfusion were observed in both patients with Tc-99m HMPAO SPECT studies.
Dirlik, A+3 more
openaire +4 more sources
Pediatrics International, 1994
AbstractMoyamoya disease is a progressive disease which involves the internal carotid arteries and its branches bilaterally. The disease is reported both in adults and in children. Moyamoya disease is frequently seen in Japanese patients having certain human leucocyte antigen (HLA) haplotypes including HLA‐Aw24, Bw46 and Bw54.
MEHMET K.+6 more
openaire +4 more sources
AbstractMoyamoya disease is a progressive disease which involves the internal carotid arteries and its branches bilaterally. The disease is reported both in adults and in children. Moyamoya disease is frequently seen in Japanese patients having certain human leucocyte antigen (HLA) haplotypes including HLA‐Aw24, Bw46 and Bw54.
MEHMET K.+6 more
openaire +4 more sources
Neurology, 2000
To the Editor: Some years ago I was asked by an asymptomatic cotwin of a patient with PD whether an [18F]dopa PET scan could predict whether he would develop the illness. Vieregge et al.’s article1 is the second recent study examining the progress of asymptomatic twins identified as having abnormal, and putatively presymptomatic, scans. The editor and
P. K. Morrish+5 more
openaire +3 more sources
To the Editor: Some years ago I was asked by an asymptomatic cotwin of a patient with PD whether an [18F]dopa PET scan could predict whether he would develop the illness. Vieregge et al.’s article1 is the second recent study examining the progress of asymptomatic twins identified as having abnormal, and putatively presymptomatic, scans. The editor and
P. K. Morrish+5 more
openaire +3 more sources
The Lancet, 2005
A 10-year-old twin girl presented elsewhere with weight gain and growth retardation. At age 14 years she was diagnosed with Cushing’s disease, and transsphenoidal pituitary tumour resection was attempted without improvement. She presented to the National Institutes of Health at age 15 years with cerebral MRI showing persistent tumour.
Joshua G. Kouri, Edward H. Oldfield
openaire +3 more sources
A 10-year-old twin girl presented elsewhere with weight gain and growth retardation. At age 14 years she was diagnosed with Cushing’s disease, and transsphenoidal pituitary tumour resection was attempted without improvement. She presented to the National Institutes of Health at age 15 years with cerebral MRI showing persistent tumour.
Joshua G. Kouri, Edward H. Oldfield
openaire +3 more sources